Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Eurofins DiscoverX Opens Shanghai Office | Contract Pharma

What are you searching for?

Sign in
Breaking News

Eurofins DiscoverX Opens Shanghai Office

Can more readily provide its product menu cell lines, assay reagents, enzymes and bioassay kits to the China market.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Eurofins DiscoverX, a global provider of products for small and large molecule drug discovery and QC lot release, opened its new China biotechnology office in Shanghai.
 
The launch of Eurofins DiscoverX (Shanghai) Ltd. broadens its Asia-Pacific operations directly into the China market. This expansion establishes an operational base positioned to serve China’s growing biopharmaceutical sector with high-quality innovative products to help accelerate drug discovery programs.
 
With this fully operational Shanghai office, Eurofins DiscoverX can more readily provide its product menu cell lines, assay reagents, enzymes and bioassay kits to the China market. The new Shanghai operation aim to provide an efficient supply chain, local technical support, and the convenience for clients to pay in the Chinese Yuan (RMB) currency.
 
This operational expansion allows Eurofins DiscoverX to provide end-to-end support every step of the way for global customers with a comprehensive menu of innovative and qualified products for drug discovery screening and QC lot release.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics